Rhythm Pharmaceuticals (RYTM) Total Debt (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Total Debt of $108.5 million for Q1 2026, down 0.96% year-over-year from $109.5 million in Q1 2025, and little changed quarter-over-quarter from $108.2 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Total Debt (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Total Debt for 6 consecutive years, with $108.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Debt fell 0.96% year-over-year to $108.5 million; the TTM figure through Mar 2026 stood at $108.5 million (down 0.96% YoY), while the FY2025 annual figure was $108.2 million, down 1.48% from the prior year.
- Total Debt steadied at $108.5 million in Q1 2026 per RYTM's latest filing, from $108.2 million in the prior quarter.
- Across five years, Total Debt topped out at $109.8 million in Q4 2024 and bottomed at $34.3 million in Q2 2022.
- Historically, Total Debt has averaged $96.5 million across 5 years, with a median of $108.5 million in 2026.
- Annual changes were most pronounced in 2024 — Total Debt climbed 3.45% — and 2025, when it declined 1.48%.
- Rhythm Pharmaceuticals' Total Debt stood at $73.0 million in 2022, then surged by 45.48% to $106.1 million in 2023, then grew by 3.45% to $109.8 million in 2024, then dropped by 1.48% to $108.2 million in 2025, then climbed by 0.27% to $108.5 million in 2026.
- Business Quant data shows RYTM's Total Debt at $108.5 million in Q1 2026, $108.2 million in Q4 2025, and $109.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | 106.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106.10 Mn |
| Mar 31, 2026 | 108.47 Mn |
| Dec 31, 2025 | 108.18 Mn |
| Sep 30, 2025 | 108.97 Mn |
| Jun 30, 2025 | 109.79 Mn |
| Mar 31, 2025 | 109.52 Mn |
| Dec 31, 2024 | 109.81 Mn |
| Dec 31, 2023 | 106.14 Mn |
| Sep 30, 2022 | 72.96 Mn |
| Jun 30, 2022 | 34.27 Mn |
| Dec 31, 2016 | 105,000.00 |